Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy

Sodium-Glucose Cotransporter 2 Inhibitors First Strategy Improve Decongestion in Patients with Symptomatic Heart Failure and Reduced Ejection Fraction When Compared to Angiotensin Receptor Neprilysin Inhibitor First Strategy

Background: Angiotensin receptor neprilysin inhibitor (ARNI) and sodium-glucose cotransporter 2 inhibitor (SGLT2i) are emerging medical treatments for decompensated heart failure (HF) with reduced ejection fraction. In clinical practice, the combination of ARNI and SGLT2i cannot be administered owin...

Full description

Bibliographic Details
Main Authors: Wei-Chieh Lee, Wei-Ting Chang, Chon-Seng Hong, Chia-Te Liao, Po-Sen Huang, Shen-Chung Huang, Chih-Hsien Lin, Chun-Yen Chiang, Zhih-Cherng Chen, Jhih-Yuan Shih
Format: Article
Language:English
Published: IMR Press 2023-04-01
Series:Frontiers in Bioscience-Landmark
Subjects:
heart failure with reduced ejection fraction
angiotensin receptor neprilysin inhibitor
sacubitril/valsartan
sodium-glucose cotransporter 2 inhibitors
decongestion
early combination
Online Access:https://www.imrpress.com/journal/FBL/28/4/10.31083/j.fbl2804081

Internet

https://www.imrpress.com/journal/FBL/28/4/10.31083/j.fbl2804081

Similar Items